All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Vitiligo refers to an acquired, idiopathic, and common de-pigmentation disorder of the skin \[[@pone.0163806.ref001]\]. The clinically characteristic symptoms of the vitiligo are pale or milk-white macules or patches due to the selective destruction of melanocytes. They occur on the skin in different parts of the body and sometimes also on the mucous membranes. The exact pathogenesis of vitiligo is still to be elucidated. Multiple mechanisms, including metabolic abnormalities, oxidative stress, generation of inflammatory mediators, cell detachment and autoimmune responses, might contribute to the pathogenesis. In particular, the autoimmune mechanism is now clearly established. Vitiligo may appear at any age and affect both sexes. It tends to occur or recur in spring and/or summer \[[@pone.0163806.ref002], [@pone.0163806.ref003]\].

Some previous reports on vitiligo epidemiology were based on population surveys, while others were performed in patients of dermatology clinics. However, the prevalence of vitiligo varies in different geographic regions and different sample size, and the data have limitations and localizations. Besides, the disorder afflicts various ethnic populations with varying prevalence estimates ranging from 0.1% to 2.0% based on the general populations in previous studies \[[@pone.0163806.ref004], [@pone.0163806.ref005]\]. But recently, some papers suggested that previous epidemiological data were exaggerated. To date, no meta-analysis on the prevalence of vitiligo has been conducted. Accordingly, it seems that an international and pooled estimate based on the various populations is necessary.

The main objective of this meta-analysis is to summarize all available data to give a description of a worldwide picture on the prevalence of vitiligo. The information was collected from both population- or community studies and hospital-based studies. Various epidemiological characteristics of vitiligo were studied in order to understand this disease more clearly.

Materials and Methods {#sec006}
=====================

Search Strategy {#sec007}
---------------

We conducted a systematic search of scientific databases, including EMBASE, PubMed, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang database and Weipu database to find relevant papers published from inception to May 2016. The search medical subject heading (MeSH) terms and keywords were "vitiligo" OR "leucoderma" AND "prevalence" OR "epidemiology". In addition, a manual search was supplemented by verifying a secondary review of the reference lists of key publications to confirm additional relevant citations.

Inclusion and Exclusion Criteria {#sec008}
--------------------------------

The criteria of included studies were as follows: (1) had sufficient information to estimate the pooled prevalence of vitiligo; (2) population-based, community-based or hospital-based; (3) published in either English or Chinese language.

The exclusion criteria of studies were: (1) irrelevant to vitiligo; (2) irrelevant to our topic; (3) review; (4) duplicate data.

Data Extraction {#sec009}
---------------

The whole potentially relevant information from the included studies was independently reviewed by two investigators (Yuhui Zhang, Meihui Shi) using a standardized form which was designed in advance. When there was a disagreement about whether selecting articles should be resolved for analysis or not, a third investigator (Yunfei Cai) made the final decision. The following information was extracted from each suitable study: first author's name, years of publication, country, survey age, gender of the participants, survey year, total sample size, numbers of vitiligo and prevalence rate.

Data Analysis {#sec010}
-------------

All statistical analyses were made using Stata software (version 12.0; Stata Corporation, College Station, Texas, USA) and the meta package was used to produce the pooled estimates, forest plots and publication bias assessment. Initially, the pooled prevalence estimates of vitiligo and 95% confidence intervals (CIs) were calculated assuming a fixed-effect model when significant heterogeneity was absent (*P*\>0.1, I^2^\<50%). If significant heterogeneity was present (*P*\<0.1, I^2^\>50%), a random-effect model was selected. To determine possible causes of heterogeneity, subgroup analyses were conducted by areas, years of publication, gender, and age. The areas covered Asia (India, China, Saudi Arabia, Sri Lanka, Turkey, Nepal, Iran, Korea, Kuwait, Thailand, Japan, Jordan), Africa (Tanzania, Egypt, Mali, Mozambique, Nigeria, Congo), America (USA, Brazil, Mexico, West Indies), Europe (Denmark, Sweden, Italy, Germany, Romania, France), Oceania (Australia) and Atlantic (Faroe Islands). For publication years, studies were grouped into eight periods, including 1 period before 80s and 7 periods after 80s with an interval of 5 years. For subgroup analysis according to age, it was grouped into four sections with an interval of 20 years. Publication bias was assessed by visually inspecting funnel plots and applying Egger's tests to evaluate sources of variability. For all tests, *P* value \< 0.1 was considered to be statistically significant.

Results {#sec011}
=======

Literature search {#sec012}
-----------------

A total of 1731 titles and/or abstracts of relevant studies were retrieved, and 1586 papers were removed due to irrelevance or review. The full-texts of remaining 145 papers were further reviewed, and 42 papers were excluded because of duplication and not providing sufficient information. Finally, 103 studies met the inclusion criteria and were included in this meta-analysis \[[@pone.0163806.ref006]--[@pone.0163806.ref108]\]. The flow chart of study selection process was shown in [Fig 1](#pone.0163806.g001){ref-type="fig"}.

![Flow diagram of the study selection process.\
Flow diagram of the study selection process.](pone.0163806.g001){#pone.0163806.g001}

Study characteristics {#sec013}
---------------------

Of the 103 studies, 82 were population- or community-based studies and 22 were hospital-based studies. The countries were Faroe Islands, India, Denmark, USA, Australia, Sweden, Brazil, China, Italy, Germany, Tanzania, Saudi Arabia, Romania, Sri Lanka, Egypt, France, Turkey, Mali, Mozambique, Nepal, Iran, Korea, Mexico, Kuwait, West Indies, Thailand, Nigeria, Japan, Congo, Jordan and the areas covered Asia, Africa, America, Europe, Oceania and Atlantic. The years of publication ranged from 1964 to 2015. The sample size of included studies ranged from 102 to 50593516. The prevalence of vitiligo ranged from 0.004% to 9.98%. The characteristics of included studies were summarized in [Table 1](#pone.0163806.t001){ref-type="table"}.

10.1371/journal.pone.0163806.t001

###### Characteristics of studies on the prevalence of vitiligo.

![](pone.0163806.t001){#pone.0163806.t001g}

  First Author                                     Publication Year   Country         Survey Age (years)   Survey Year      Sample (N)   Vitiligo (n)   Prevalence
  ------------------------------------------------ ------------------ --------------- -------------------- ---------------- ------------ -------------- ------------
  Population or community-based studies                                                                                                                 
  Lomholt G \[[@pone.0163806.ref006]\]             1964               Faroe Islands   all                  \-               10984        7              0.06%
  Mehta NR \[[@pone.0163806.ref007]\]              1973               India           all                  1971\~1972       9065         138            1.52%
  Howitz J \[[@pone.0163806.ref008]\]              1977               Denmark         all                  1971\~1972       47033        179            0.38%
  Johnson MT \[[@pone.0163806.ref009]\]            1978               USA             1\~74                1971\~1974       20749        102            0.49%
  Quirk CJ \[[@pone.0163806.ref010]\]              1979               Australia       adults               \-               1037         12             1.16%
  Larsson PA \[[@pone.0163806.ref011]\]            1980               Sweden          12\~17               \-               8298         33             0.40%
  Weismann K \[[@pone.0163806.ref012]\]            1980               Denmark         55\~106              \-               584          7              1.20%
  Bechelli LM \[[@pone.0163806.ref013]\]           1981               Brazil          6\~16                1974\~1975       9955         4              0.04%
  Zhou YH \[[@pone.0163806.ref014]\]               1985               China           all                  1985             13390        1              0.01%
  Das SK \[[@pone.0163806.ref015]\]                1985               India           ≥3                   1978\~1982       15685        72             0.46%
  Montagnani A \[[@pone.0163806.ref016]\]          1985               Italy           1month\~12years      1979\~1982       1273         12             0.94%
  Nanda A \[[@pone.0163806.ref017]\]               1989               India           ≤6 weeks             1986             310          1              0.32%
  Schallreuter KU \[[@pone.0163806.ref018]\]       1991               Germany         14\~86               1989             350          2              0.57%
  Xue SQ \[[@pone.0163806.ref019]\]                1994               China           42\~60               1992             5683         72             1.27%
  Cellini A \[[@pone.0163806.ref020]\]             1994               Italy           23\~79               1990\~1992       526          2              0.38%
  Wang WX \[[@pone.0163806.ref021]\]               1994               China           all                  1984\~1985       316379       294            0.09%
  Gibbs S \[[@pone.0163806.ref022]\]               1996               Tanzania        all                  \-               1114         3              0.27%
  Guan JC \[[@pone.0163806.ref023]\]               1997               China           15\~20               1997             2206         1              0.05%
  Bhatia V \[[@pone.0163806.ref024]\]              1997               India           0\~14                1988\~1989       666          4              0.60%
  Kubeyinje EP \[[@pone.0163806.ref025]\]          1997               Saudi Arabia    18\~45               1991\~1995       1520         5              0.33%
  Ren XL \[[@pone.0163806.ref026]\]                1998               China           \-                   \-               155000       15             0.01%
  Sun TQ \[[@pone.0163806.ref027]\]                1999               China           1\~79                1996             78021        93             0.12%
  Liao WQ \[[@pone.0163806.ref028]\]               1999               China           \-                   1997             3560         4              0.11%
  Popescu R \[[@pone.0163806.ref029]\]             1999               Romania         6\~12                1995             1114         3              0.27%
  Perera A \[[@pone.0163806.ref030]\]              2000               Sri Lanka       all                  1997             1806         22             1.22%
  Ling WJ \[[@pone.0163806.ref031]\]               2001               China           \-                   1999\~2000       102          1              0.98%
  Xie PL \[[@pone.0163806.ref032]\]                2001               China           0\~7                 \-               23052        1              0.004%
  Che DF \[[@pone.0163806.ref033]\]                2001               China           \-                   1998\~1999       3160         2              0.06%
  Sun ZX \[[@pone.0163806.ref034]\]                2001               China           0\~7                 1999\~2000       10804        2              0.02%
  Zhang JQ \[[@pone.0163806.ref035]\]              2002               China           21\~51               1999             641          3              0.47%
  Zhang BX \[[@pone.0163806.ref036]\]              2002               China           17\~31               1998\~2000       3761         7              0.19%
  Chen XQ \[[@pone.0163806.ref037]\]               2002               China           \-                   2001             11389        5              0.04%
  Prahalad S \[[@pone.0163806.ref038]\]            2002               USA             \-                   \-               496          2              0.40%
  Yang XQ \[[@pone.0163806.ref039]\]               2002               China           16\~24               2001\~2002       2188         20             0.91%
  El-Serag HB \[[@pone.0163806.ref040]\]           2002               USA             59.8113.41           1992\~1999       136816       130            0.10%
  Dogra S \[[@pone.0163806.ref041]\]               2003               India           6\~14                2001             12586        272            2.16%
  Abdel-Hafez K \[[@pone.0163806.ref042]\]         2003               Egypt           all                  1994\~1996       8008         98             1.22%
  Xu YY \[[@pone.0163806.ref043]\]                 2003               China           all                  \-               156461       279            0.18%
  Li PH \[[@pone.0163806.ref044]\]                 2003               China           all                  2002             13953        3              0.02%
  Wolkenstein P \[[@pone.0163806.ref045]\]         2003               France          all                  2002             18137        51             0.28%
  Zeng YH \[[@pone.0163806.ref046]\]               2004               China           6\~12                2002             17542        6              0.03%
  Feng D \[[@pone.0163806.ref047]\]                2004               China           17\~58               2000             853          4              0.47%
  Xu HZ \[[@pone.0163806.ref048]\]                 2004               China           20\~97               \-               2195         1              0.05%
  Zhao Y \[[@pone.0163806.ref049]\]                2004               China           18\~24               2002             2116         1              0.05%
  Naldi L \[[@pone.0163806.ref050]\]               2004               Italy           ≥45                  2003             3660         26             0.71%
  Tuncel AA \[[@pone.0163806.ref051]\]             2005               Turkey          14\~25               \-               682          2              0.29%
  Lin T \[[@pone.0163806.ref052]\]                 2005               China           18\~46               2004             385          1              0.26%
  Faye O \[[@pone.0163806.ref053]\]                2005               Mali            \<15                 2001             1729         4              0.23%
  Wang TL \[[@pone.0163806.ref054]\]               2006               China           17.4\~23.8           2004             34166        35             0.10%
  Song WF \[[@pone.0163806.ref055]\]               2006               China           \-                   2005             3920         2              0.05%
  Ai JZ \[[@pone.0163806.ref056]\]                 2006               China           7\~16                \-               21794        3              0.01%
  Al-Saeed WY \[[@pone.0163806.ref057]\]           2006               Saudi Arabia    6\~17                2003             2239         8              0.36%
  Lu T \[[@pone.0163806.ref058]\]                  2007               China           all                  2002\~2003       42833        40             0.09%
  Zhao G \[[@pone.0163806.ref059]\]                2007               China           18\~44               2006             324          3              0.93%
  Xu CY \[[@pone.0163806.ref060]\]                 2007               China           \-                   2007             4725         3              0.06%
  Chhaganlal K \[[@pone.0163806.ref061]\]          2007               Mozambique      0\~82                3-month period   780          1              0.13%
  El-Essawi D \[[@pone.0163806.ref062]\]           2007               USA             20\~80               \-               194          3              1.55%
  Chen GY \[[@pone.0163806.ref063]\]               2008               China           6\~11                2005             3273         3              0.09%
  Birlea SA \[[@pone.0163806.ref064]\]             2008               Romania         all                  2001\~2006       2021         3              0.15%
  Walker SL \[[@pone.0163806.ref065]\]             2008               Nepal           12 days\~80 years    \-               878          8              0.91%
  Zhao G \[[@pone.0163806.ref066]\]                2009               China           22\~57               2007\~2008       255          1              0.39%
  Zhu LB \[[@pone.0163806.ref067]\]                2009               China           all                  2007\~2008       6593         2              0.03%
  Komba EV \[[@pone.0163806.ref068]\]              2010               Tanzania        6\~19                \-               420          3              0.71%
  Liu XH \[[@pone.0163806.ref069]\]                2010               China           \-                   2007             1670         1              0.06%
  Li YF \[[@pone.0163806.ref070]\]                 2010               China           18\~53               2008             1078         3              0.28%
  Ingordo V \[[@pone.0163806.ref071]\]             2011               Italy           18                   2001\~2004       34740        60             0.17%
  Pei GD \[[@pone.0163806.ref072]\]                2011               China           18\~94               \-               2341         22             0.94%
  Wang RL \[[@pone.0163806.ref073]\]               2012               China           12\~20               2008\~2009       7747         37             0.48%
  Yamamah GA \[[@pone.0163806.ref074]\]            2012               Egypt           ≤18                  2008\~2009       2194         4              0.18%
  Liu Q \[[@pone.0163806.ref075]\]                 2013               China           12\~80               \-               2719         21             0.77%
  Wang XY \[[@pone.0163806.ref076]\]               2013               China           all                  \-               17345        122            0.70%
  Yang YS \[[@pone.0163806.ref077]\]               2013               China           17\~21               \-               1525         2              0.13%
  Pang XW \[[@pone.0163806.ref078]\]               2013               China           18\~39               2011             473          3              0.63%
  Chen JZ \[[@pone.0163806.ref079]\]               2013               China           17\~21               \-               2957         2              0.07%
  Zhu XW \[[@pone.0163806.ref080]\]                2014               China           18\~93               2012             3993         2              0.05%
  Shao ZQ \[[@pone.0163806.ref081]\]               2014               China           \-                   2011             986          1              0.10%
  El-Khateeb EA \[[@pone.0163806.ref082]\]         2014               Egypt           6\~12                2011\~2012       6162         4              0.06%
  Reddy J \[[@pone.0163806.ref083]\]               2014               India           all                  \-               22037        160            0.73%
  Afkhami-Ardekani M \[[@pone.0163806.ref084]\]    2014               Iran            10\~98               2011             1100         20             1.82%
  Lee H \[[@pone.0163806.ref085]\]                 2015               Korea           all                  2009\~2011       50593516     63467          0.13%
  Chen YT \[[@pone.0163806.ref086]\]               2015               China           all                  1997\~2011       23254688     14883          0.06%
  Liu TH \[[@pone.0163806.ref087]\]                2015               China           17\~43               2014             1347         2              0.15%
  Hospital-based studies                                                                                                                                
  Ruiz-Maldonado R \[[@pone.0163806.ref088]\]      1977               Mexico          0\~18                1971\~1975       10000        260            2.60%
  Anand IS \[[@pone.0163806.ref089]\]              1998               India           0\~12                1994             400          8              2.00%
  Nanda A \[[@pone.0163806.ref090]\]               1999               Kuwait          0\~12                1992\~1996       10000        149            1.49%
  Boisseau-Garsaud AM \[[@pone.0163806.ref091]\]   2000               West Indies     1\~96                1995\~1996       2077         7              0.34%
  Wisuthsarewong W \[[@pone.0163806.ref092]\]      2000               Thailand        0\~12                \-               2361         97             4.11%
  Yang XQ \[[@pone.0163806.ref093]\]               2001               China           15\~78               1990\~2000       735          6              0.82%
  Li GP \[[@pone.0163806.ref094]\]                 2003               China           \-                   2001\~2002       7796         72             0.92%
  Ogunbiyi AO \[[@pone.0163806.ref095]\]           2004               Nigeria         \-                   1994\~1998       1091         51             4.67%
  Onayemi O \[[@pone.0163806.ref096]\]             2005               Nigeria         all                  1999\~2001       2611         25             0.96%
  Nnoruka EN \[[@pone.0163806.ref097]\]            2005               Nigeria         0\~73                1999\~2001       2871         91             3.17%
  Yang QY \[[@pone.0163806.ref098]\]               2007               China           60\~93               2005\~2006       599          2              0.33%
  El-Essawi D \[[@pone.0163806.ref062]\]           2007               USA             20\~80               \-               207          5              2.42%
  Tamer E \[[@pone.0163806.ref099]\]               2008               Turkey          0\~16                2004\~2006       6300         91             1.44%
  Taylor A \[[@pone.0163806.ref100]\]              2008               USA             ≥12                  \-               140          1              0.71%
  Ayanlowo O \[[@pone.0163806.ref101]\]            2009               Nigeria         \-                   2003\~2006       6645         186            2.80%
  Poojary SA \[[@pone.0163806.ref102]\]            2011               India           \-                   2002\~2008       33252        204            0.61%
  Furue M \[[@pone.0163806.ref103]\]               2011               Japan           all                  2007\~2008       67448        1134           1.68%
  Muteba Baseke C \[[@pone.0163806.ref104]\]       2011               Congo           all                  2000\~2010       14195        204            1.44%
  Zhang LJ \[[@pone.0163806.ref105]\]              2012               China           8\~76                2009\~2011       1439         13             0.90%
  Al-Refu K \[[@pone.0163806.ref106]\]             2012               Jordan          0\~12                2-year period    2000         71             3.55%
  Kumar S \[[@pone.0163806.ref107]\]               2014               India           all                  2012             443          44             9.98%
  Su WL \[[@pone.0163806.ref108]\]                 2014               China           ≥60                  2011\~2013       1094         2              0.18%

The results of pooled meta-analysis {#sec014}
-----------------------------------

Based on the results of random-effects method, the prevalence of vitiligo from population- or community-based studies was 0.2% (95%CI: 0.1%--0.2%) and from hospital-based studies was 1.8% (95%CI: 1.4%--2.1%). The forest plots of vitiligo prevalence were shown in Figs [2](#pone.0163806.g002){ref-type="fig"} and [3](#pone.0163806.g003){ref-type="fig"}.

![Forest plot of prevalence from population- or community-based studies.\
Forest plot of prevalence of vitiligo from population- or community-based studies from 1964 to 2015.](pone.0163806.g002){#pone.0163806.g002}

![Forest plot of prevalence from hospital-based studies.\
Forest plot of prevalence of vitiligo from hospital-based studies from 1977 to 2014.](pone.0163806.g003){#pone.0163806.g003}

The subgroup analyses of population- or community-based studies ([Table 2](#pone.0163806.t002){ref-type="table"}) {#sec015}
-----------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0163806.t002

###### Prevalence of vitiligo stratified by different factors.
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                                          Stratified factors   No. of Studies   Prevalence rate   Lower limit   Upper limit   Heterogeneity I^2^ (%)   *P* from test of heterogeneity   Model
  --------------------------------------- -------------------- ---------------- ----------------- ------------- ------------- ------------------------ -------------------------------- --------
  Population or community-based studies                                                                                                                                                 
  Area                                                                                                                                                                                  
                                          Asia                 57               0.001             0.001         0.002         99.50%                   0                                Random
                                          Africa               7                0.004             0.001         0.007         93.10%                   0                                Random
                                          America              5                0.002             0.001         0.004         94.80%                   0                                Random
                                          Europe               11               0.004             0.002         0.005         83.90%                   0                                Random
                                          Oceania              1                0.012             0.005         0.018         \-                       \-                               Random
                                          Atlantic             1                0.001             0             0.001         \-                       \-                               Random
  Years                                                                                                                                                                                 
                                          1964\~1980           7                0.006             0.004         0.009         97.30%                   0                                Random
                                          1981\~1985           4                0.002             0.001         0.003         96.20%                   0                                Random
                                          1986\~1990           1                0.003             -0.003        0.009         \-                       \-                               Random
                                          1991\~1995           4                0.006             -0.001        0.013         95.40%                   0                                Random
                                          1996\~2000           9                0.001             0.001         0.002         93.00%                   0                                Random
                                          2001\~2005           23               0.002             0.002         0.003         97.10%                   0                                Random
                                          2006\~2010           17               0.001             0             0.001         77.90%                   0                                Random
                                          2011\~2015           17               0.002             0.002         0.002         99.80%                   0                                Random
  Gender                                                                                                                                                                                
                                          male                 30               0.002             0.002         0.003         94.10%                   0                                Random
                                          female               18               0.005             0.004         0.006         95.00%                   0                                Random
  Age                                                                                                                                                                                   
                                          0\~19                26               0.002             0.002         0.003         95.80%                   0                                Random
                                          20\~39               8                0.002             0.001         0.003         83.30%                   0                                Random
                                          40\~59               7                0.004             0.003         0.006         90.20%                   0                                Random
                                          ≥60                  7                0.007             0.003         0.01          95.30%                   0                                Random
  Hospital-based studies                                                                                                                                                                
  Area                                                                                                                                                                                  
                                          Asia                 13               0.016             0.011         0.02          97.50%                   0                                Random
                                          Africa               5                0.025             0.016         0.034         95.70%                   0                                Random
                                          America              4                0.015             -0.001        0.031         97.60%                   0                                Random
  Years                                                                                                                                                                                 
                                          1964\~1980           1                0.026             0.023         0.029         \-                       \-                               Random
                                          1996\~2000           4                0.019             0.007         0.031         97.10%                   0                                Random
                                          2001\~2005           5                0.02              0.01          0.029         94.70%                   0                                Random
                                          2006\~2010           5                0.015             0.005         0.025         94.10%                   0                                Random
                                          2011\~2015           7                0.016             0.01          0.022         98.50%                   0                                Random
  Gender                                                                                                                                                                                
                                          male                 4                0.011             0.005         0.017         94.20%                   0                                Random
                                          female               4                0.013             0.007         0.02          94.60%                   0                                Random
  Age                                                                                                                                                                                   
                                          0\~19                7                0.024             0.018         0.029         93.00%                   0                                Random
                                          20\~39               1                0.014             0.012         0.016         \-                       \-                               Random
                                          40\~59               1                0.015             0.013         0.017         \-                       \-                               Random
                                          ≥60                  3                0.008             -0.005        0.02          98.50%                   0                                Random

The vitiligo prevalence of different areas were 0.1% (0.1%, 0.2%) in Asia, 0.4% (0.1%, 0.7%) in Africa, 0.2% (0.1%, 0.4%) in America, 0.4% (0.2%, 0.5%) in Europe, 1.2% (0.5%, 1.8%) in Oceania (only one study) and 0.1% (0%, 0.1%) in Atlantic, respectively.

When stratified by publication years, the prevalence of vitiligo was 0.6% (0.4%, 0.9%) before the 80s. It decreased to 0.2%\~0.3% in the 80s. The prevalence rebounded to 0.6% (-0.1%, 1.3%) in the first half of 90s. After that, the prevalence drastically decreased and maintained at a low level of 0.1%\~0.2%.

The subgroup analysis stratified by gender showed that vitiligo attacked 0.2% (0.2%, 0.3%) males in contrast to 0.5% (0.4%, 0.6%) females.

Pooled prevalence of age-groups in 0\~19 years, 20\~39 years, 40\~59 years and ≥60 years were 0.2% (0.2%, 0.3%), 0.2% (0.1%, 0.3%), 0.4% (0.3%, 0.6%) and 0.7% (0.3%, 1.0%), respectively. The prevalence in the ≥60 years age-group was the highest of the four age categories, and the prevalence of vitiligo increased with age gradually.

The subgroup analyses of hospital-based studies ([Table 2](#pone.0163806.t002){ref-type="table"}) {#sec016}
-------------------------------------------------------------------------------------------------

With regard to hospital-based studies, the prevalence of vitiligo was as high as 2.5% (1.6%, 3.4%) of Africa, compared with 1.6% (1.1%, 2.0%) of Asia and 1.5% (-0.1%, 3.1%) of America.

Before the 80s, the prevalence of vitiligo was 2.6% (2.3%, 2.9%). The data of the 80s and the first half of 90s were not available. The prevalence of the latter half of 90s and the first 5 years of 21^st^ century were 1.9% (0.7%, 3.1%) and 2.0% (1.0%, 2.9%), respectively. In recent 10 years, the prevalence has decreased to 1.5%\~1.6%. It has showed a decreased trend from 60s till now.

The prevalence of males was 1.1% (0.5%, 1.7%) in contrast to 1.3% (0.7%, 2.0%) of females.

The prevalence of age-groups in 0\~19 years, 20\~39 years, 40\~59 years and ≥60 years were 2.4% (1.8%, 2.9%), 1.4% (1.2%, 1.6%), 1.5% (1.3%, 1.7%) and 0.8% (-0.5%, 2.0%), respectively. The highest prevalence was observed in 0\~19 years and the overall prevalence showed a gradually decreased trend with age increment.

Publication Bias {#sec017}
----------------

There was significant publication bias in population- or community-based studies (t = 2.31, *P* = 0.026), while no significant publication bias existed in hospital-based studies (t = 0.47, *P* = 0.643). The funnel plot of publication bias was shown in [Fig 4](#pone.0163806.g004){ref-type="fig"}.

![Funnel plot assessing publication bias: (a) population- or community-based published studies; (b) hospital-based published studies.\
Funnel plot assessing publication bias in the prevalence of vitiligo from: (a) 82 population- or community-based published studies; (b) 22 hospital-based published studies.](pone.0163806.g004){#pone.0163806.g004}

Discussion {#sec018}
==========

To our knowledge, this is the first meta-analysis examining the prevalence of vitiligo. The results of this study showed that the pooled prevalence of 82 population- or community-based studies was 0.2% and of 22 hospital-based studies was 1.8%. The latter data derived from hospital-based surveys was obviously high.

Although vitiligo occurs worldwide, it is known that the reported prevalence of vitiligo is various. Prevalence distributions might differ in areas. In the included population- or community-based studies, the lowest prevalence was in Asia and Atlantic, the second-highest in Africa and in Europe, and the highest in Oceania. But only 1 study was included, the result of Oceania was not definite. In hospital-based studies, prevalence was the lowest in America and the highest in Africa. So we could draw a common conclusion from the two types of studies that Africa had a high prevalence of vitiligo. These results were in accordance with previous studies that vitiligo frequently occurred in darker-skinned individuals \[[@pone.0163806.ref109]\]. However, differences did exist in various reports. We suspect the differences that vitiligo is more prevalent in some geographic areas may result from the following factors. Firstly, different skin types and ethnic groups may play important roles in the discrepancy of the prevalence among different areas. Environmental conditions as well as genetic factors may solely or synergistically contribute to the various prevalence distribution in different geographic areas \[[@pone.0163806.ref007]\]. Secondly, the populations in many surveys were ethnically and culturally diverse such as the survey in USA. Several generations of immigrants or various population\'s lifestyles in this region might contribute to these differences. Thirdly, unbalanced number of included studies in geographic regions might compromise accurate and sufficient information for heterogeneity. Studies were extremely more conducted in Asia, while only 1 study was conducted in Oceania or Atlantic. Lastly, small amounts of participants in some included studies may contribute to imprecise estimates.

In general, the prevalence of vitiligo showed a relatively decreased trend with increase in the times. Especially, it has remained at a low level in recent two decades in both population- or community-based studies and hospital-based studies. The association between vitiligo and its autoimmune diseases, such as autoimmune thyroid diseases, psoriasis, pernicious anemia, Addison's disease et al has been frequently described in the literatures. As vitiligo may accompany with other diseases or disorders, we assume that the decreasing prevalence may be beneficial from development of diagnostic tools or improvement of screening programs or therapeutic methods of vitiligo-related diseases or disorders. The prevalence went up to 0.6% in the first half of 90s in population- or community-based studies. We found there was a literature written by Xue SQ about skin diseases of workers and technical personnel in Taigang company. The prevalence of vitiligo of this community population reached 1.27%, higher than other papers in this period. Chemical elements or decolorization may result in the increase of patients with vitiligo. The exact etiology and pathogenesis of vitiligo have not been completely unraveled. It involves a series of known and unknown environmental factors or immunological factors acting over time.

Our results also demonstrated that the pooled prevalence of vitiligo was slightly higher in females than in males, both for the population- or community-based studies (0.5% compared with 0.2%) and the hospital-based studies (1.3% compared with 1.1%). This result was different from previous literatures, which revealed that male and female patients were affected equally by vitiligo \[[@pone.0163806.ref004], [@pone.0163806.ref058], [@pone.0163806.ref110]\] or men were more affected than women \[[@pone.0163806.ref111]\]. Women usually incline to concern about pigmentation changes of their skin and the impact on their social life, and women may be more diligent in seeking treatment. This could be a possible reason for the greater number of female patients in this study \[[@pone.0163806.ref112]\].

Besides, this study revealed that the prevalence of vitiligo increased with age in population- or community-based studies, increasing gradually from 0.2% in the 0\~19 years age-group to 0.7% in the ≥ 60 years age-group. Similar results have been found in some previous studies \[[@pone.0163806.ref008], [@pone.0163806.ref058]\]. The increase possibly correlates to a cumulative effect, because vitiligo is a long-lasting disease and is life-long in most patients. However, in hospital-based studies, the prevalence in the 0\~19 years age-group was higher than that in the ≥ 60 years age-group. Youngers may occupy more important position in the family and parents will take them to see a doctor as soon as they find the children's conditions. In contrast, some elderly patients do not pay greater awareness of their appearance and will not see doctors unless necessary.

Despite we have conducted a comprehensive searching of the epidemiology of vitiligo, several limitations should be considered in this meta-analysis. The available publications/studies were from 31 countries. The data of unavailable countries are required to reflect the wide variation. Some characteristics of the patients, such as clinical types, site or age of onset, risk factors, etc., were not included in the subgroup analyses. These might exert an important influence on the prevalence of vitiligo. Another possible limitation of this study was related to publication bias. The result from Egger's test showed an evidence of publication bias in population- or community-based studies. It may result from unbalanced number of studies and year of publications. For example, the number of included studies of 2001\~2005 was 23, in contrast, the number of 1986\~1990 was only 1. Finally, some included studies had noted methodological flaws, especially related to selection and recruitment of samples. Special subjects, such as soldiers, teachers, miners and other professional workers, participating in the investigations could not be representative of other samples. Control group with other diseases such as diabetes was also selected in some studies. As a result, the estimates of prevalence may have been influenced in unpredictable ways and need continuous perfectibility for verifying our conclusion.

In conclusion, we investigated a worldwide prevalence of vitiligo with population- or community-based and hospital-based data. A relatively high prevalence of vitiligo was found in Africa area and in female patients. The prevalence has maintained at a low level in recent years. It showed an inverse trend with age increment in the two types of studies. The current study provided a basic result for further studies. Future researches should be done to find key factors that contribute to the prevalence.
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